Here is the latest shareholding Pattern of BERYL DRUGS. For more details, see the BERYL DRUGS financial fact sheet and BERYL DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 24.92 | 24.92 | 24.92 | 26.38 | 26.38 | 26.38 | 26.38 | 26.38 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 24.92 | 24.92 | 24.92 | 26.38 | 26.38 | 26.38 | 26.38 | 26.38 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 3.25 | 2.58 | 2.42 | 2.42 | 2.41 | 2.62 | 2.79 | 4.46 | |
Individuals | % | 68.72 | 69.34 | 69.16 | 67.89 | 67.95 | 67.87 | 67.51 | 66.26 | |
NRIs/OCBs | % | 0.73 | 0.86 | 0.87 | 0.82 | 0.82 | 0.83 | 0.86 | 0.94 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.38 | 2.30 | 2.63 | 2.49 | 2.44 | 2.30 | 2.46 | 1.96 | |
Total Non-Institution | % | 75.08 | 75.08 | 75.08 | 73.62 | 73.62 | 73.62 | 73.62 | 73.62 | |
Total Public | % | 75.00 | 75.00 | 75.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.